Duality Advisers’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-54,526
| Closed | -$2.26M | – | 668 |
|
|
2023
Q2 | $2.26M | Buy |
54,526
+38,540
| +241% | +$1.6M | 0.28% | 132 |
|
|
2023
Q1 | $961K | Sell |
15,986
-14,994
| -48% | -$902K | 0.11% | 307 |
|
|
2022
Q4 | $2.27M | Buy |
30,980
+24,683
| +392% | +$1.81M | 0.26% | 122 |
|
|
2022
Q3 | $478K | Sell |
6,297
-25,534
| -80% | -$1.94M | 0.05% | 427 |
|
|
2022
Q2 | $2.21M | Buy |
+31,831
| New | +$2.21M | 0.22% | 177 |
|
|
2022
Q1 | – | Sell |
-15,466
| Closed | -$1.16M | – | 771 |
|
|
2021
Q4 | $1.16M | Sell |
15,466
-648
| -4% | -$48.6K | 0.13% | 265 |
|
|
2021
Q3 | $1.87M | Buy |
16,114
+10,002
| +164% | +$1.16M | 0.14% | 253 |
|
|
2021
Q2 | $1.36M | Buy |
6,112
+1,179
| +24% | +$262K | 0.12% | 284 |
|
|
2021
Q1 | $652K | Buy |
+4,933
| New | +$652K | 0.06% | 413 |
|